The Limited Times

Now you can see non-English news...

Novavax vaccine 89% effective according to clinical trials

2021-01-28T22:04:55.710Z


Clinical trials of Novavax's Covid-19 vaccine have shown an efficacy of 89.3%, the US biotech company said in a statement Thursday posting the results of phase 3 trials involving more than 15,000 people. Read also: Covid-19 vaccination: schedule, Pfizer and Moderna difference, side effects ... The point to know everything “ NVX-CoV2373 has the potential to play an important role in solving this


Clinical trials of Novavax's Covid-19 vaccine have shown an efficacy of 89.3%, the US biotech company said in a statement Thursday posting the results of phase 3 trials involving more than 15,000 people.

Read also: Covid-19 vaccination: schedule, Pfizer and Moderna difference, side effects ... The point to know everything

NVX-CoV2373 has the potential to play an important role in solving this global public health crisis

,” said company CEO Stanley Erck.

Read also: Coronavirus: the EU is considering a vaccine contract with Novavax

But the positive news was offset by the joint announcement that the vaccine is much less effective against the variant first identified in South Africa, which scientists consider to be more contagious.

Source: lefigaro

All news articles on 2021-01-28

You may like

Trends 24h

News/Politics 2024-03-27T16:45:54.081Z
News/Politics 2024-03-28T06:04:53.137Z

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.